发明名称 NEW SOLID DOSE FORM OF NANOPARTICULATE NAPROXEN
摘要 Described are solid dose nanoparticulate naproxen formulations having high rates of dissolution. The solid dose nanoparticulate naproxen formulations c an comprise an alkali compound, which functions to increase the dissolution rat e of the naproxen following administration. Alternatively, the solid dose nanoparticulate naproxen formulation can comprise an alkali compound and an acidic compound, which can react together to form carbon dioxide. The formed carbon dioxide can also aid in increasing the dissolution rate of the naprox en following administration. Also described are solid dose nanoparticulate naproxen formulations having decreased concentration of a binder/disintegran t agent. Such compositions also provide an increased rate of dissolution of naproxen following administration.
申请公布号 CA2342309(C) 申请公布日期 2003.10.28
申请号 CA19992342309 申请日期 1999.08.19
申请人 ELAN PHARMA INTERNATIONAL LIMITED 发明人 JAIN, RAJEEV A.;WEI, LINDEN;SWANSON, JON
分类号 A61K9/51;A61K9/14;A61K9/20;A61K9/46;A61K31/192;A61K47/04;A61K47/12;A61K47/14;A61K47/20;A61K47/22;A61K47/26;A61K47/34;A61P25/04;A61P29/00;(IPC1-7):A61K9/20;A61K9/00;A61K31/19 主分类号 A61K9/51
代理机构 代理人
主权项
地址